JN BIOTECH ApS: Financial statements 2023
CVR: 25325001
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
JN BIOTECH ApS (CVR 25325001) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 114,774 and a net result of DKK 150,483 compared with DKK 338,399 the year before. That is an increase of 39.8% compared with the year before. Equity in the 2023 report amounted to DKK 655,759. The solvency ratio was 54.1%.
- Gross Profit
- DKK 114,774
- Profit/Loss
- DKK 150,483
- Equity
- DKK 655,759
- Total Assets
- DKK 1,213,154
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 115K | 150K | 656K | 0 |
| 2022 | - | 82K | 338K | 3M | 0 |
| 2021 | - | 116K | 1.6M | 15.7M | 0 |
| 2018 | - | 73K | 12.8M | 13.7M | 0 |
| 2017 | - | 81K | 103K | 872K | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout JN BIOTECH ApS
JN BIOTECH ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Andre personlige serviceydelser i.a.n.. The management consists of Jens Bredal Nielsen. The company is owned by JBN Biotech ApS. The company has 1 employee (2006). In 2025, the company reported a gross profit of DKK 90,325 and a net result of DKK 104,408 compared with DKK 60,995 the year before. Equity in the 2025 report amounted to DKK 821,161.